To mark 2011, we have asked our distinguished OncologySTAT Advisory Board Members to choose their top story of the year. Dr. Axel Grothey discusses his choice for the year’s most important development in colorectal cancer research. OncologySTAT: In your view, which development in oncology research that occurred in 2011 could have the most significant impact on treatment of colorectal cancer?Dr. Grothey: In 2011, we saw something that we haven’t seen in more than 8 years—agents that have improved...